Cell cultures, whether or not modified; cell therapy products

HS v2022 Code: 300251

About cell cultures, whether or not modified; cell therapy products

HS code 300251 covers the production and trade of cell cultures, whether modified or not, as well as cell therapy products. This industry plays a crucial role in the broader healthcare and pharmaceutical sectors, enabling the development of advanced medical treatments and therapies. Cell cultures and cell therapy products are essential for research, drug discovery, and the production of various biological and biotechnological products that improve human health and well-being.

Production process

The production of cell cultures and cell therapy products typically involves the cultivation of cells in controlled laboratory environments. This process often utilizes specialized cell culture media, bioreactors, and other advanced equipment to maintain optimal conditions for cell growth and proliferation. Depending on the specific application, cells may be genetically modified or manipulated to exhibit desired characteristics. The final products are then carefully processed, packaged, and distributed for use in various medical and research applications.

Production inputs

The main inputs required for the production of cell cultures and cell therapy products include cell lines, cell culture media, bioreactors, and other specialized laboratory equipment. Additionally, skilled personnel with expertise in cell biology, biotechnology, and quality control are essential for the successful cultivation and processing of these products. Regulatory compliance and adherence to strict quality standards are also critical inputs in this industry.

Production outputs

The primary outputs of HS code 300251 are cell cultures and cell therapy products, which are used in a wide range of applications, including 300215 Medicaments containing vitamins or other products of heading 2936, 300220 Vaccines for human medicine, and 300290 Medicaments consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not elsewhere specified or included. These products are essential for drug development, regenerative medicine, and the advancement of various medical and scientific research initiatives.

Revisions to 300251

Classification codes are adjusted frequently. The code may have been revised or replaced between system versions. The table below shows the history (newest to oldest) of the code 300251. The most recent 1 version of this code (300251) is in the HS v2022 system (this version):

This page shows the most recent version of code 300251.

Family tree for cell cultures, whether or not modified; cell therapy products

    graph LR
    A["<a href='/classifications/hs/v2022/30'>30: Pharmaceutical products</a>"]
A --> B["<a href='/classifications/hs/v2022/3002'>3002: Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc</a>"]
B --> C["<a href='/classifications/hs/v2022/300251'>300251: Cell cultures, whether or not modified; cell therapy products</a>"]

    B --> D["<a href='/classifications/hs/v2022/300212'>300212: Blood, human or animal, antisera, other blood fractions and immunological products; antisera and other blood fractions</a>"]
B --> E["<a href='/classifications/hs/v2022/300213'>300213: Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale</a>"]
B --> F["<a href='/classifications/hs/v2022/300214'>300214: Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, mixed, put up in measured doses or in forms or packings for retail sale</a>"]
B --> G["<a href='/classifications/hs/v2022/300215'>300215: Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, put up in measured doses or in forms or packings for retail sale</a>"]
B --> H["<a href='/classifications/hs/v2022/300241'>300241: Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; for human medicine</a>"]
B --> I["<a href='/classifications/hs/v2022/300242'>300242: Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; for veterinary medicine</a>"]
B --> J["<a href='/classifications/hs/v2022/300249'>300249: Toxins, cultures of micro-organisms (excluding yeasts) and similar products; n.e.c. in item 3002.3</a>"]
B --> K["<a href='/classifications/hs/v2022/300259'>300259: Cell cultures, whether or not modified; other cell cultures not including cell therapy products</a>"]
B --> L["<a href='/classifications/hs/v2022/300290'>300290: Toxins, cultures of micro-organisms (excluding yeasts) and similar products</a>"]

    

    %% Color coordination by level

    classDef level1 color:#000,fill:#a8f9ff,stroke:#333,stroke-width:2px
    classDef level2 color:#000,fill:#e0a458,stroke:#333,stroke-width:1px
    classDef level3 color:#000,fill:#419d78,stroke:#333,stroke-width:1px
    classDef level4 color:#000,fill:#c04abc,stroke:#333,stroke-width:1px
    classDef level5 color:#000,fill:#f1c40f,stroke:#333,stroke-width:1px
    classDef level6 color:#000,fill:#f1c40f,stroke:#333,stroke-width:1px
    classDef highlight color:#000,fill:#fff,stroke:#000,stroke-width:5px



  %% Apply classes
  class A level2
class B level4
class C level6
class D level6
class E level6
class F level6
class G level6
class H level6
class I level6
class J level6
class K level6
class L level6

  class C highlight

  %% class A level1
  %% class B,C level2
  %% class D,E,F,G,H,I level2
  %% class J,K,L,M,N,O,P level3
  %% class C highlight